Literature DB >> 12867412

DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF.

Amanda L Gavin1, Djemel Aït-Azzouzene, Carl F Ware, David Nemazee.   

Abstract

The tumor necrosis family member BAFF is limiting for the survival of follicular B lymphocytes, but excessive BAFF signaling can lead to autoimmunity, suggesting that its activity must be tightly regulated. We have identified a conserved alternate splice isoform of BAFF, called deltaBAFF, which lacks 57 nt encoding the A-A1 loop and is co-expressed with BAFF in many mouse and human myeloid cells. Mouse deltaBAFF appears on the plasma membrane, but unlike BAFF it is inefficiently released by proteolysis. DeltaBAFF can associate with BAFF in heteromultimers and diminish BAFF bioactivity and release. Thus, alternative splicing of the BAFF gene suppresses BAFF B cell stimulatory function in several ways, and deltaBAFF may promote other functions as well.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867412      PMCID: PMC3792716          DOI: 10.1074/jbc.M306852200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death.

Authors:  K Kelly; E Manos; G Jensen; L Nadauld; D A Jones
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

2.  Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene.

Authors:  E Ayroldi; F D'Adamio; O Zollo; M Agostini; R Moraca; L Cannarile; G Migliorati; D V Delfino; C Riccardi
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

3.  APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.

Authors:  G Yu; T Boone; J Delaney; N Hawkins; M Kelley; M Ramakrishnan; S McCabe; W R Qiu; M Kornuc; X Z Xia; J Guo; M Stolina; W J Boyle; I Sarosi; H Hsu; G Senaldi; L E Theill
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

4.  STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.

Authors:  T Nosaka; T Kawashima; K Misawa; K Ikuta; A L Mui; T Kitamura
Journal:  EMBO J       Date:  1999-09-01       Impact factor: 11.598

5.  The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis.

Authors:  W C Powell; B Fingleton; C L Wilson; M Boothby; L M Matrisian
Journal:  Curr Biol       Date:  1999 Dec 16-30       Impact factor: 10.834

6.  Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice.

Authors:  S D Khare; I Sarosi; X Z Xia; S McCabe; K Miner; I Solovyev; N Hawkins; M Kelley; D Chang; G Van; L Ross; J Delaney; L Wang; D Lacey; W J Boyle; H Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

7.  Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.

Authors:  R K Do; E Hatada; H Lee; M R Tourigny; D Hilbert; S Chen-Kiang
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

8.  BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population.

Authors:  J S Thompson; P Schneider; S L Kalled; L Wang; E A Lefevre; T G Cachero; F MacKay; S A Bixler; M Zafari; Z Y Liu; S A Woodcock; F Qian; M Batten; C Madry; Y Richard; C D Benjamin; J L Browning; A Tsapis; J Tschopp; C Ambrose
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

Review 9.  APRIL and BAFF connect autoimmunity and cancer.

Authors:  C F Ware
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

10.  Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo.

Authors:  H Nishimura; T Yajima; Y Naiki; H Tsunobuchi; M Umemura; K Itano; T Matsuguchi; M Suzuki; P S Ohashi; Y Yoshikai
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

View more
  25 in total

1.  Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of concept.

Authors:  N Roescher; J L Vosters; G Alsaleh; P Dreyfus; S Jacques; G Chiocchia; J Sibilia; P P Tak; J A Chiorini; X Mariette; Jacques-Eric Gottenberg
Journal:  Mol Ther       Date:  2013-12-05       Impact factor: 11.454

2.  Causal variants in autoimmune disease: a commentary on a recent published fine-mapping algorithm analysis in genome-wide association studies study.

Authors:  Jiunn-Diann Lin; Chao-Wen Cheng
Journal:  Ann Transl Med       Date:  2017-03

3.  Differential induction of plasma cells by isoforms of human TACI.

Authors:  Yolanda Garcia-Carmona; Montserrat Cols; Adrian T Ting; Lin Radigan; Frank J Yuk; Li Zhang; Andrea Cerutti; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2015-01-28       Impact factor: 22.113

Review 4.  BAFF inhibition in SLE-Is tolerance restored?

Authors:  Shaun W Jackson; Anne Davidson
Journal:  Immunol Rev       Date:  2019-09-28       Impact factor: 12.988

Review 5.  The BAFF/APRIL system in SLE pathogenesis.

Authors:  Fabien B Vincent; Eric F Morand; Pascal Schneider; Fabienne Mackay
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

6.  Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice.

Authors:  Julie Lang; Bicheng Zhang; Margot Kelly; Jacob N Peterson; Jacob Barbee; Brian M Freed; James P Di Santo; Jennifer L Matsuda; Raul M Torres; Roberta Pelanda
Journal:  Blood Adv       Date:  2017-12-19

7.  Regulation of the B cell receptor repertoire and self-reactivity by BAFF.

Authors:  Miyo Ota; Bao H Duong; Ali Torkamani; Colleen M Doyle; Amanda L Gavin; Takayuki Ota; David Nemazee
Journal:  J Immunol       Date:  2010-09-03       Impact factor: 5.422

Review 8.  Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.

Authors:  Stéphanie Haiat; Christian Billard; Claire Quiney; Florence Ajchenbaum-Cymbalista; Jean-Pierre Kolb
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

9.  Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma.

Authors:  Anne J Novak; Susan L Slager; Zachary S Fredericksen; Alice H Wang; Michelle M Manske; Steven Ziesmer; Mark Liebow; William R Macon; Stacey R Dillon; Thomas E Witzig; James R Cerhan; Stephen M Ansell
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

Review 10.  The BLyS family: toward a molecular understanding of B cell homeostasis.

Authors:  John F Treml; Yi Hao; Jason E Stadanlick; Michael P Cancro
Journal:  Cell Biochem Biophys       Date:  2008-11-26       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.